Showing results (351-360 of 405) with videos related to

Sort By:
Pageof 41
The European Respiratory Journal|July 9, 2011
Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradientsS J Scheidl, C Englisch, G Kovacs, et al.
American Journal of Respiratory and Critical Care Medicine|January 1, 1996
Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edemaA Günther, C Siebert, R Schmidt, et al.
Neurosurgery|August 1, 1996
Cerebrospinal fluid shunting in idiopathic normal-pressure hydrocephalus of the elderly: effect of periventricular and deep white matter lesionsJ K Krauss, D W Droste, W Vach, et al.
Cancer Gene Therapy|September 27, 2008
Intravenous injection of siRNA directed against hypoxia-inducible factors prolongs survival in a Lewis lung carcinoma cancer modelF Kamlah, B G Eul, S Li, et al.
The European Respiratory Journal|May 28, 2002
Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on gas exchange and haemodynamicsD Walmrath, F Grimminger, D Pappert, et al.
The European Respiratory Journal|September 1, 1996
Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedemaH Schütte, J Lohmeyer, S Rosseau, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 20, 2000
Subthreshold doses of specific phosphodiesterase type 3 and 4 inhibitors enhance the pulmonary vasodilatory response to nebulized prostacyclin with improvement in gas exchangeR T Schermuly, A Roehl, N Weissmann, et al.
The European Respiratory Journal|February 26, 2004
Inhaled iloprost is a potent acute pulmonary vasodilator in HIV-related severe pulmonary hypertensionH A Ghofrani, G Friese, T Discher, et al.
The European Respiratory Journal|December 2, 2008
Regulation of hypoxic pulmonary vasoconstriction: basic mechanismsN Sommer, A Dietrich, R T Schermuly, et al.
Annals of Internal Medicine|March 25, 2000
Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study GroupH Olschewski, H A Ghofrani, T Schmehl, et al.
Pageof 41